Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Decitabine”

416 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 416 results

Testing effectiveness (Phase 2)Study completedNCT03303339
What this trial is testing

Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Cardiff Oncology 72
Testing effectiveness (Phase 2)Study completedNCT00054431
What this trial is testing

Imatinib Mesylate and Decitabine in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaBlastic Phase Chronic Myelogenous LeukemiaChildhood Chronic Myelogenous Leukemia+2 more
National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Ended earlyNCT04113616
What this trial is testing

An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 When Administered Alone and in Combination With Low-Dose Cytarabine (LDAC) or Decitabine in Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Relapsed or Refractory Acute Myeloid Leukemia (AML)Acute Myeloid Leukemia (AML), Secondary to Myeloproliferative Neoplasms (MPN)
Kartos Therapeutics, Inc. 70
Large-scale testing (Phase 3)Not Yet RecruitingNCT05907499
What this trial is testing

Decitabine for Poor Graft Function Post Allo-HSCT

Who this might be right for
Poor Graft Function
The First Affiliated Hospital of Soochow University 76
Testing effectiveness (Phase 2)Study completedNCT00416598
What this trial is testing

Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia With Myelodysplasia-Related ChangesAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11+4 more
National Cancer Institute (NCI) 546
Testing effectiveness (Phase 2)Study completedNCT04146038
What this trial is testing

Salsalate, Venetoclax, and Decitabine or Azacitidine for the Treatment of Acute Myeloid Leukemia or Advanced Myelodysplasia/Myeloproliferative Disease

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyeloblasts 10 Percent or More of Bone Marrow Nucleated Cells+5 more
Rutgers, The State University of New Jersey 5
Testing effectiveness (Phase 2)Ended earlyNCT03404193
What this trial is testing

Venetoclax and Decitabine in Treating Participants With Relapsed/Refractory Acute Myeloid Leukemia or Relapsed High-Risk Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeBlastic Plasmacytoid Dendritic Cell Neoplasm+12 more
M.D. Anderson Cancer Center 235
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07435636
What this trial is testing

Modulation of Stem Cell Differentiation in Individuals With High Risk Clonal Haematopoiesis

Who this might be right for
Clonal Cytopenia of Uncertain SignificanceCCUS Clonal Cytopenia of Undetermined SignificanceClonal Hematopoiesis
Clinical Hub for Interventional Research (CHOIR) 80
Testing effectiveness (Phase 2)Looking for participantsNCT04872543
What this trial is testing

ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST)

Who this might be right for
Malignant Peripheral Nerve Sheath Tumors (MPNST)
Memorial Sloan Kettering Cancer Center 25
Large-scale testing (Phase 3)UnknownNCT04087967
What this trial is testing

Study of DAC Combined With HAAG Regimen in Newly Diagnosed Younger AML Patients

Who this might be right for
Acute Myeloid LeukemiaInduction Chemotherapy
The First Affiliated Hospital of Soochow University 162
Early research (Phase 1)Looking for participantsNCT05636514
What this trial is testing

Combined Evaluation of Epigenetic and Sensitising Therapy in AML and MDS

Who this might be right for
Myelodysplastic SyndromesChronic Myelomonocytic LeukemiaAcute Myeloid Leukemia
Clinical Hub for Interventional Research (CHOIR) 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT04476199
What this trial is testing

Venetoclax and Decitabine Assessment in Patients (≥60 - <75 Years) with Newly Diagnosed AML Eligible for Allo-SCT

Who this might be right for
Acute Myeloid Leukemia
Gruppo Italiano Trapianto di Midollo Osseo 100
Large-scale testing (Phase 3)Ended earlyNCT02785900
What this trial is testing

Vadastuximab Talirine (SGN-CD33A; 33A) Combined With Azacitidine or Decitabine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Seagen Inc. 240
Testing effectiveness (Phase 2)Study completedNCT02109744
What this trial is testing

Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients

Who this might be right for
Acute Myelogenous Leukemia
University of Rochester 27
Testing effectiveness (Phase 2)Ended earlyNCT03113071
What this trial is testing

Safety and Activity of Digoxin With Decitabine in Adult AML and MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Fox Chase Cancer Center 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT04697940
What this trial is testing

Decitabine-primed Tandem CD19/CD20 CAR T Cells Treatment in r/r B-NHL

Who this might be right for
Relapsed and Refractory B-cell Non-Hodgkin's LymphomaDecitabine-primed Tandem CD19/CD20 CAR T Cells
Han weidong 33
Not applicableNo Longer AvailableNCT01026376
What this trial is testing

An Expanded Access Program for Decitabine in Patients With Myelodysplastic Syndrome (MDS)

Who this might be right for
Myelodysplastic Syndromes
Janssen-Cilag Farmaceutica Ltda.
Testing effectiveness (Phase 2)UnknownNCT04279379
What this trial is testing

Sintilimab and Decitabine for Patients With Relapsed/Refractory or Advanced NK/T-cell Lymphoma

Who this might be right for
Extranodal NK/T-cell Lymphoma
Beijing Tongren Hospital 20
Testing effectiveness (Phase 2)Study completedNCT01794702
What this trial is testing

Decitabine Followed by Clofarabine, Idarubicin, and Cytarabine in Acute Leukemia

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 65
Testing effectiveness (Phase 2)Ended earlyNCT00740181
What this trial is testing

Decitabine, Cytarabine, GCSF for Refractory AML/MDS

Who this might be right for
MyelodysplasiaLeukemia
Brown University 9
Load More Results